Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism
- PMID: 20696966
- DOI: 10.1001/archinternmed.2010.199
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism
Abstract
Background: The Pulmonary Embolism Severity Index (PESI) estimates the risk of 30-day mortality in patients with acute pulmonary embolism (PE). We constructed a simplified version of the PESI.
Methods: The study retrospectively developed a simplified PESI clinical prediction rule for estimating the risk of 30-day mortality in a derivation cohort of Spanish outpatients. Simplified and original PESI performances were compared in the derivation cohort. The simplified PESI underwent retrospective external validation in an independent multinational cohort (Registro Informatizado de la Enfermedad Tromboembólica [RIETE] cohort) of outpatients.
Results: In the derivation data set, univariate logistic regression of the original 11 PESI variables led to the removal of variables that did not reach statistical significance and subsequently produced the simplified PESI that contained the variables of age, cancer, chronic cardiopulmonary disease, heart rate, systolic blood pressure, and oxyhemoglobin saturation levels. The prognostic accuracy of the original and simplified PESI scores did not differ (area under the curve, 0.75 [95% confidence interval (CI), 0.69-0.80]). The 305 of 995 patients (30.7%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.0% (95% CI, 0.0%-2.1%) compared with 10.9% (8.5%-13.2%) in the high-risk group. In the RIETE validation cohort, 2569 of 7106 patients (36.2%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.1% (95% CI, 0.7%-1.5%) compared with 8.9% (8.1%-9.8%) in the high-risk group.
Conclusion: The simplified PESI has similar prognostic accuracy and clinical utility and greater ease of use compared with the original PESI.
Similar articles
-
A comparison of the original and simplified Pulmonary Embolism Severity Index.Thromb Haemost. 2011 Sep;106(3):423-8. doi: 10.1160/TH11-04-0263. Epub 2011 Jun 28. Thromb Haemost. 2011. PMID: 21713328
-
Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.Ann Am Thorac Soc. 2015 Aug;12(8):1122-9. doi: 10.1513/AnnalsATS.201504-202OC. Ann Am Thorac Soc. 2015. PMID: 26114586
-
[Comparative evaluation of prognostic scores in pulmonary embolism ].Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):69-74. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23077875 Romanian.
-
Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy.Curr Opin Pulm Med. 2008 Sep;14(5):414-21. doi: 10.1097/MCP.0b013e3283043e44. Curr Opin Pulm Med. 2008. PMID: 18664971 Review.
-
The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis.Respir Res. 2012 Dec 4;13(1):111. doi: 10.1186/1465-9921-13-111. Respir Res. 2012. PMID: 23210843 Free PMC article. Review.
Cited by
-
Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study.J Pharm Policy Pract. 2024 Nov 19;17(1):2418367. doi: 10.1080/20523211.2024.2418367. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39568792 Free PMC article.
-
Pleural effusion in acute pulmonary embolism: characteristics and relevance.BMJ Open Respir Res. 2024 Nov 13;11(1):e002179. doi: 10.1136/bmjresp-2023-002179. BMJ Open Respir Res. 2024. PMID: 39537424 Free PMC article.
-
Comorbidity profiles and pulmonary embolism risk assessment: Leveraging the Charlson Comorbidity Index for improved prognostication in a national data set.Pulm Circ. 2024 Nov 7;14(4):e70010. doi: 10.1002/pul2.70010. eCollection 2024 Oct. Pulm Circ. 2024. PMID: 39512785 Free PMC article.
-
Development of the Pulmonary Embolism Progression (PEP) score for predicting short-term clinical deterioration in intermediate-risk pulmonary embolism: a single-center retrospective study.J Thromb Thrombolysis. 2024 Oct 22. doi: 10.1007/s11239-024-03051-5. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 39438395
-
Risk Stratification and Management of Intermediate- and High-Risk Pulmonary Embolism.J Clin Med. 2024 Sep 20;13(18):5583. doi: 10.3390/jcm13185583. J Clin Med. 2024. PMID: 39337073 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
